Pharmaceuticals

Drug Development Drug Pricing Weight Loss Drugs Drug Approval Prescription Drugs Clinical Trials Diabetes Treatment Drug Manufacturing Drug Safety Vaccines

Trump Gives Pharma Until September 29 to Match Lowest Global Drug Prices

The White House has warned 17 drugmakers they must match the lowest global prices by September 29 under his Most Favored Nation strategy.

Pfizer Beats Q2 Earnings Estimates, Raises Annual Profit Forecast

Hims & Hers Posts Q2 Revenue Shortfall as Shares Slide

Stories older than 24h

Trump Gives Pharma CEOs 60 Days to Adopt Most-Favored-Nation Drug Pricing

FDA Mandates Opioid Label Overhaul to Quantify Long-Term Risks

Novo Nordisk Cuts 2025 Outlook and Names New CEO as Shares Plunge

US-EU Trade Deal Imposes 15% Tariff on European Drugs

IonQ Declares Quantum Supremacy Just Months Away

EU Backs First Twice-Yearly Injectable for HIV Prevention

EMA Committee Recommends EU Approval for First Oral Postpartum Depression Treatment

Experts Criticize FDA’s Unbalanced Review of SSRIs in Pregnancy

AstraZeneca Commits $50 Billion to U.S. Manufacturing and Research by 2030

FDA Begins Expert Review of Menopause Hormone Therapy Warnings

Johnson & Johnson Tops Q2 Estimates, Raises Full-Year Outlook

WHO Recommends Six-Monthly Lenacapavir Injection for HIV Prevention

Comprehensive Review Finds Five OTC Supplements Backed by Strong Depression Trials

Bristol-Myers Squibb Faces 33% Q2 EPS Drop as Dividend Holds at 5.2%

WHO Endorses Twice-Yearly Lenacapavir Injections for HIV Prevention

Swissmedic Approves First Malaria Treatment for Newborns Under 4.5 kg

House Judiciary Committee Subpoenas Pfizer Scientist Over 2020 Vaccine Timing Allegations